CyclASol® Phase 1 Study

NCT02113293 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CyclASol®
DRUG: Placebo (vehicle)

Sponsor

Novaliq GmbH